Linked Life Data

17729412

Source:http://linkedlifedata.com/resource/pubmed/id/17729412

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
34
pubmed:dateCreated
2007-8-30
pubmed:abstractText
To evaluate the significance of BNIP3 in the pathogenesis of pancreatic cancer, we analyzed the relationship between the expression of BNIP3 and survival rate of the patients with pancreatic cancer, or chemosensitivities in pancreatic cancer cell lines, particularly for gemcitabine, the first-line anti-tumor drug for pancreatic cancer.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
1007-9327
pubmed:author
pubmed:issnType
Print
pubmed:day
14
pubmed:volume
13
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
4593-7
pubmed:dateRevised
2010-11-18
pubmed:meshHeading
pubmed-meshheading:17729412-Antimetabolites, Antineoplastic, pubmed-meshheading:17729412-Cell Line, Tumor, pubmed-meshheading:17729412-Cell Proliferation, pubmed-meshheading:17729412-Cell Survival, pubmed-meshheading:17729412-Deoxycytidine, pubmed-meshheading:17729412-Dose-Response Relationship, Drug, pubmed-meshheading:17729412-Drug Resistance, Neoplasm, pubmed-meshheading:17729412-Female, pubmed-meshheading:17729412-Gene Expression Regulation, Neoplastic, pubmed-meshheading:17729412-Humans, pubmed-meshheading:17729412-Inhibitory Concentration 50, pubmed-meshheading:17729412-Kaplan-Meier Estimate, pubmed-meshheading:17729412-Male, pubmed-meshheading:17729412-Membrane Proteins, pubmed-meshheading:17729412-Middle Aged, pubmed-meshheading:17729412-Pancreatic Neoplasms, pubmed-meshheading:17729412-Prognosis, pubmed-meshheading:17729412-Proto-Oncogene Proteins, pubmed-meshheading:17729412-RNA, Messenger, pubmed-meshheading:17729412-Treatment Outcome
pubmed:year
2007
pubmed:articleTitle
Elucidation of the relationship of BNIP3 expression to gemcitabine chemosensitivity and prognosis.
pubmed:affiliation
Department of Molecular Pathology, Tohoku University School of Medicine, 2-1 Seiryo-machi, Sendai, Japan.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't